NDC Code(s) : 24236-292-22
Packager : REMEDYREPACK INC.
Category : HUMAN PRESCRIPTION DRUG LABEL
DEA Schedule : none
Marketing Status : New Drug Application
INGREDIENTS AND APPEARANCE
Atriplaefavirenz, emtricitabine, and tenofovir disoproxil fumarate TABLET, FILM COATED | ||||||||||||||||||||||||||
|
||||||||||||||||||||||||||
|
||||||||||||||||||||||||||
|
||||||||||||||||||||||||||
|
||||||||||||||||||||||||||
|
||||||||||||||||||||||||||
|
PRINCIPAL DISPLAY PANEL
DRUG: Atripla
GENERIC: efavirenz, emtricitabine, and tenofovir disoproxil fumarate
DOSAGE: TABLET, FILM COATED
ADMINSTRATION: ORAL
NDC: 24236-292-22
COLOR: pink
SHAPE: OVAL
SCORE: No score
SIZE: 20 mm
IMPRINT: 123
PACKAGING: 150 in 1 CANISTER
ACTIVE INGREDIENT(S):
- EFAVIRENZ 600mg in 1
- EMTRICITABINE 200mg in 1
- TENOFOVIR DISOPROXIL FUMARATE 300mg in 1
INACTIVE INGREDIENT(S):
- CROSCARMELLOSE SODIUM
- POLYVINYL ALCOHOL
- FERRIC OXIDE RED
- POLYETHYLENE GLYCOL 3350
- TALC
- FERROSOFERRIC OXIDE
- HYDROXYPROPYL CELLULOSE (TYPE H)
- MAGNESIUM STEARATE
- SODIUM LAURYL SULFATE
- CELLULOSE, MICROCRYSTALLINE
- TITANIUM DIOXIDE